​​​​Global Coalition on Aging and Pfizer Medical Grants Partner to Tackle Vaccine Hesitancy in Super-Aging Japan

The unique partnership supports innovative research to increase use of recommended vaccines among Japan’s older adult population

New York, NEW YORK (February 17, 2021) – The Global Coalition on Aging and Pfizer Global Medical Grants announced today the launch of the first of its grant projects under the Japan-focused VALUE Initiative (Vaccines for All: Longevity Unleashed for Everyone), which has provided up to $1 million USD in grant awards. Grant recipients include Keio University, the Health and Global Policy Institute (HGPI), and the International Longevity Centre-UK. The three VALUE projects are poised to generate critical insights for both policy and practice about how to increase vaccine use among older adults and to better understand vaccine hesitancy in the Japanese context. The VALUE Initiative and its grantees will together contribute important evidence of how to extend the benefits of immunization to older adults at a critical global moment where immunizing adults is central and essential to relief from the Covid-19 pandemic.

The first VALUE project to launch, Moving the needle, Improving uptake of adult vaccination in Japan, is an innovative ethnographic initiative led by the International Longevity Centre – UK (ILC) and Stripe Partners.

“We are honored and delighted to see our first grantee – the ILC-UK and Stripe Partners – beginning work on their project, which is designed to increase the uptake of vaccinations for people aged 65 and over in Japan,” said Michael Hodin, CEO Global Coalition on Aging.  “When we conceived this grant program back in 2019 with Pfizer Global Medical Grants, we knew of the huge need to enhance adult vaccines as a critical part of prevention-focused health strategies in Japan, and therefore as a model for global lessons, especially as the WHO and UN were planning their launch of the Decade of Healthy Ageing.  And, now with older adults most at risk of severe illness and death from Covid-19 and the attendant need for their immunization, the importance of the program takes on an even greater sense of urgency.”

Immediate action is critical, especially as there will soon be 2 billion globally over 60, and, for the first time in the history of humanity, more old than young. When vaccines are not utilized or under-utilized, the result is an increased vulnerability to several diseases – including shingles, pneumococcal disease, and influenza. As we age, vaccinations can improve quality of life by reducing risks for morbidity and disability and have the potential to increase life expectancy, while having positive impacts on healthcare costs, especially hospitalization, readmissions and physician visits.

“VALUE is a very exciting initiative and a great example of the positive outcomes we can achieve through public/private partnerships,” said Dr. John Beard, Chair of the Global Coalition on Aging Advisory Council, former Director of Ageing and Life Course at the WHO, and member of the Expert Panel that evaluated grant proposals for the VALUE Initiative. “Linking VALUE to global interests in healthy and active aging through the WHO Decade of Healthy Ageing will enable us to learn from Japan even as this initiative contributes to better outcomes for Japan’s aging population itself.”

Along with Dr. Beard and Mr. Hodin, the VALUE Expert Panel includes Dr. Mitsunobu Kano, Okayama University; Dr. Bennett Lee, Pfizer Japan; Dr. Stefania Maggi, European Interdisciplinary Council on Aging; Dr. Kenji Shibuya, King’s College London; and Professor Brigita Skela-Savič, International Council of Nurses.

“By working in partnership with government leaders, NGOs, and professional health and medical associations, the VALUE Initiative will bring greater attention to the need, opportunity, and pathways for solutions and uncover strategies that can measurably increase the number of older adults who are immunized against preventable diseases,” said Hodin. “It is our hope that Japan can become a model for healthier longevity that developed and developing countries alike can follow.”

About Pfizer Global Medical Grants

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.